HOCPY
Price
$131.01
Change
+$1.31 (+1.01%)
Updated
Dec 17 closing price
48 days until earnings call
SSMXY
Price
$19.21
Change
+$0.06 (+0.31%)
Updated
Dec 17 closing price
49 days until earnings call
Ad is loading...

HOCPY vs SSMXY

Header iconHOCPY vs SSMXY Comparison
Open Charts HOCPY vs SSMXYBanner chart's image
Hoya
Price$131.01
Change+$1.31 (+1.01%)
Volume$18.06K
CapitalizationN/A
Sysmex
Price$19.21
Change+$0.06 (+0.31%)
Volume$121.99K
CapitalizationN/A
HOCPY vs SSMXY Comparison Chart
Loading...
HOCPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SSMXY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOCPY vs. SSMXY commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOCPY is a Hold and SSMXY is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (HOCPY: $131.01 vs. SSMXY: $19.21)
Brand notoriety: HOCPY and SSMXY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HOCPY: 117% vs. SSMXY: 191%
Market capitalization -- HOCPY: $41.52B vs. SSMXY: $14.31B
HOCPY [@Medical Specialties] is valued at $41.52B. SSMXY’s [@Medical Specialties] market capitalization is $14.31B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOCPY’s FA Score shows that 0 FA rating(s) are green whileSSMXY’s FA Score has 1 green FA rating(s).

  • HOCPY’s FA Score: 0 green, 5 red.
  • SSMXY’s FA Score: 1 green, 4 red.
According to our system of comparison, SSMXY is a better buy in the long-term than HOCPY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOCPY’s TA Score shows that 2 TA indicator(s) are bullish while SSMXY’s TA Score has 6 bullish TA indicator(s).

  • HOCPY’s TA Score: 2 bullish, 7 bearish.
  • SSMXY’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SSMXY is a better buy in the short-term than HOCPY.

Price Growth

HOCPY (@Medical Specialties) experienced а -2.06% price change this week, while SSMXY (@Medical Specialties) price change was -5.09% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.05%. For the same industry, the average monthly price growth was +4.04%, and the average quarterly price growth was +1.93%.

Reported Earning Dates

HOCPY is expected to report earnings on Feb 04, 2025.

SSMXY is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Medical Specialties (-2.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOCPY($41.5B) has a higher market cap than SSMXY($14.3B). SSMXY has higher P/E ratio than HOCPY: SSMXY (42.55) vs HOCPY (34.84). HOCPY YTD gains are higher at: 5.557 vs. SSMXY (4.315). HOCPY has higher annual earnings (EBITDA): 267B vs. SSMXY (102B). HOCPY has more cash in the bank: 426B vs. SSMXY (70.3B). SSMXY has less debt than HOCPY: SSMXY (22.6B) vs HOCPY (24.6B). HOCPY has higher revenues than SSMXY: HOCPY (734B) vs SSMXY (411B).
HOCPYSSMXYHOCPY / SSMXY
Capitalization41.5B14.3B290%
EBITDA267B102B262%
Gain YTD5.5574.315129%
P/E Ratio34.8442.5582%
Revenue734B411B179%
Total Cash426B70.3B606%
Total Debt24.6B22.6B109%
FUNDAMENTALS RATINGS
HOCPY vs SSMXY: Fundamental Ratings
HOCPY
SSMXY
OUTLOOK RATING
1..100
7284
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
56100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5253
P/E GROWTH RATING
1..100
6273
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SSMXY's Valuation (19) in the null industry is somewhat better than the same rating for HOCPY (60). This means that SSMXY’s stock grew somewhat faster than HOCPY’s over the last 12 months.

HOCPY's Profit vs Risk Rating (56) in the null industry is somewhat better than the same rating for SSMXY (100). This means that HOCPY’s stock grew somewhat faster than SSMXY’s over the last 12 months.

HOCPY's SMR Rating (99) in the null industry is in the same range as SSMXY (100). This means that HOCPY’s stock grew similarly to SSMXY’s over the last 12 months.

HOCPY's Price Growth Rating (52) in the null industry is in the same range as SSMXY (53). This means that HOCPY’s stock grew similarly to SSMXY’s over the last 12 months.

HOCPY's P/E Growth Rating (62) in the null industry is in the same range as SSMXY (73). This means that HOCPY’s stock grew similarly to SSMXY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOCPYSSMXY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 13 days ago
67%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 6 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Ad is loading...
HOCPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SSMXY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGICX17.94N/A
N/A
Virtus KAR Equity Income C
CVMIX17.95N/A
N/A
Calvert Emerging Markets Equity I
CMRGX10.06N/A
N/A
Calamos Merger Arbitrage I
MSGGX14.00-0.09
-0.64%
Meridian Small Cap Growth Legacy
VVORX21.53-0.44
-2.00%
Invesco Value Opportunities R

HOCPY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOCPY has been loosely correlated with TRUMY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HOCPY jumps, then TRUMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOCPY
1D Price
Change %
HOCPY100%
+1.01%
TRUMY - HOCPY
47%
Loosely correlated
-0.20%
SSMXY - HOCPY
42%
Loosely correlated
+0.31%
ISRG - HOCPY
38%
Loosely correlated
+0.58%
OLYMY - HOCPY
36%
Loosely correlated
+0.11%
SMTI - HOCPY
34%
Loosely correlated
+0.47%
More

SSMXY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SSMXY has been loosely correlated with TRUMY. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SSMXY jumps, then TRUMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SSMXY
1D Price
Change %
SSMXY100%
+0.31%
TRUMY - SSMXY
45%
Loosely correlated
-0.20%
HOCPY - SSMXY
44%
Loosely correlated
+1.01%
OLYMY - SSMXY
33%
Loosely correlated
+0.11%
ESLOY - SSMXY
31%
Poorly correlated
-0.51%
ISRG - SSMXY
28%
Poorly correlated
+0.58%
More